The RESPOND Programme
Outcomes and Testimonials
We are now finalising our results from work package 3. The mean response time was calculated across all three primary sites and across all three epochs.
These epochs were:
- Epoch 1 – before March 2022
- Epoch 2 – between March and October 2022
- Epoch 3 – from October 2022 to May 2023
Three of the four RESPOND interventions were introduced in each site in March 2022. The fourth RESPOND intervention, the Surgical Escalation Procedure, was introduced in all three sites in October 2022.
The graph above demonstrates an overall improvement in response time (in minutes) from before and after the RESPOND interventions.
We’ve also heard positive feedback from leaders in each of the three sites from work package 3:
- “If you have been working in an environment for some time, you can argue it is easy to assume certain procedures are of common knowledge. However, with the high turn-over of staff, use of bank/agency resources, and high workload, this user-friendly summary of “what can I do” is key to supporting the juniors. Although we do have our policies and procedures, working in an unfamiliar environment, or unfamiliar situations could cause confusion and oversight." Misha Denise Virtudazo, CCOT Lead; MET Lead Nurse; Divisional Non-Medical Research Lead (WMX), in reference to the SEPs
- “RESPOND trial ignites team dynamics, engagement and awareness fostering interprofessional relationships and communication improving response and outcomes in surgical patients that deteriorate during their care. It has been enlightening to focus on human factors as a necessary skill to improve clinical care.” Ms Brooke Puttergill Endocrine and General Emergency Surgeon, RESPOND Trial Pilot Stoke Mandeville Hospital
More data to be posted shortly once all work package three results have been finalised.